TGFB1 and breast carcinoma: Genetic manipulation of TGF-β ligands or receptors in oncogenic murine mammary carcinoma models has demonstrated a growth inhibitory role for TGF-β signalling in the early stages of tumourigenesis but enhanced metastatic progression in advanced disease [10,11,12,13,14].